With increasing choice of medications and devices for asthma and chronic obstructive
pulmonary disease (COPD) treatment, comparative evidence may inform treatment …

Many inhaler devices with varying handling requirements for optimal use are available for
the treatment of asthma and chronic obstructive pulmonary disease (COPD). Patients may …

OBJECTIVE: To compare healthcare resource utilization and healthcare costs between
COPD patients who used multiple long-acting inhalers versus those who used a single long …

Importance The benefits and harms of adding long-acting muscarinic antagonists (LAMAs)
to inhaled corticosteroids (ICS) and long-acting β 2-agonists (LABAs) for moderate to severe …

Background Patients with COPD may be prescribed multiple inhalers as part of their
treatment regimen, which require different inhalation techniques. Previous literature has …

Background Switching inhalers to cheaper equivalent products is often advocated as a
necessary cost saving measure, yet the impact on patient's health and healthcare utilisation …

Pressure on healthcare budgets is increasing, while at the same time patent protection for
many branded inhaled medications has expired, leading to the development and growing …

Objectives In some studies comparing triple with dual combination therapies in COPD there
might be a possible effect of inhaler bias resulting from different inhaler devices being used …

BACKGROUND: Selection of inhaler device type appears to influence real-world
effectiveness of inhaled corticosteroids (ICS), but data are lacking on the role of inhaler …

Background: Appropriate use of inhaled therapies for asthma and chronic obstructive
pulmonary disease (COPD) is critical to ensuring good patient outcomes, efficient use of …